1. Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma
   Cinzia Lanzi et al, 2019, Cancers CrossRef
2. Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
   Hans Gelderblom et al, 2017, Acta Oncologica CrossRef
3. CT-morphologic and CT-textural patterns of response in inoperable soft tissue sarcomas treated with pazopanib—a preliminary retrospective cohort study
   Michael Esser et al, 2019, The British Journal of Radiology CrossRef
4. A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice
   Yi-Kun Wang et al, 2019, Xenobiotica CrossRef